Skip to content

Slow-wave Sleep Deprivation in Depression

Slow-wave Sleep Deprivation as a Possible Treatment for Major Depressive Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01189591
Enrollment
25
Registered
2010-08-26
Start date
2009-06-30
Completion date
2011-08-31
Last updated
2017-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Brief summary

Sleep deprivation can acutely reverse depressive symptoms in patients with major depression. Although underlying mechanisms of the antidepressant action in sleep deprivation are unclear, many of these observations can be explained by abnormal slow wave homeostasis. This study will test the prediction that selectively reducing slow waves during sleep (slow wave deprivation; SWD), without disrupting total sleep time, will yield an antidepressant effect.

Detailed description

see above

Interventions

DEVICESlow-wave deprivation

Using acoustic tones to suppress slow-wave sleep

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

* Among the inclusion criteria will be: * age range 18-35 years * right handedness * major depressive disorder according to DSM-IV (Diagnostic and Statical Manual-Revision 4) criteria (as determined by the Structured Clinical Interview for Diagnostic and Statical Manual-Revision 4), with Hamilton Rating Scale for \*Depression scores of at least 18 on the first 17 items * no psychotropic medications for at least 4 weeks * no joint and muscular di * normal hearing * regular bedtimes and sleep duration, no time zone shifts in the last three weeks.

Exclusion criteria

* Diabetes requiring insulin treatment * A serious heart disorder or subjects who have had a heart attack within the last 3 months * A diagnosis of cancer in the past 3 years and/or has active neoplastic disease * Clinically significant abnormalities on pre-study physical exam or physician evaluation * Subjects who meet DSM-IV (Diagnostic and Statical Manual-Revision 4) criteria for alcohol/drug abuse problems within the last six months or are currently using illegal drugs. * Female subjects of child-bearing potential who are pregnant or planning to become pregnant. * Women of child-bearing must be practicing a medically acceptable form of birth control. * Women of childbearing potential will be questioned about pregnancy status and form of birth control to be used at each visit. * Women who are unsure of their pregnancy status will be given a urine pregnancy test. * Subjects taking investigational medications * Subjects currently undergoing electroconvulsive therapy (ECT) or therapeutic transcranial magnetic stimulation (TMS). * Subjects who regularly perform night or late evening shift work (e.g. - second or third shifts) or have had travel with time zone shifts \>3h in the last 3 weeks

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Scale24 hours

Secondary

MeasureTime frameDescription
Inventory of Depressive Symptomology24 hoursrating scale of mood

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026